In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Series G lands $25mm for EarlySense

Executive Summary

EarlySense Ltd. (contact-free continuous monitoring solutions) raised $25mm in Series G funding led by Bank Hapoalim, which was joined by Pitango Venture Capital, JK&B Capital, and other previous backers. The company will use the proceeds to drive the growth of its FDA-approved and CE-marked under-mattress sensor devices for tracking heart rate, respiratory rate, and movement.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Monitoring Equipment & Devices
  • In Vitro Diagnostics
    • Biosensors
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies